O. Vesterqvist - Concepedia

Author

O. Vesterqvist

Karolinska University Hospital

Also Known As

O VESTERQVIST, O Vesterqvist, O. VESTERQVIST, O. Vesterqvist, Ole L. Vesterqvist, Ole Vesterqvist

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Karolinska University Hospital Bristol-Myers Squibb (United States)Integrated Cardio Metabolic Centre Bristol-Myers Squibb (Germany)Wake Forest University

About

O. Vesterqvist is an author at Karolinska University Hospital specializing in medicine, pharmacology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	975
2	Biochemistry	3	3	112
3	Biostatistics	2	2	234
4	Health Sciences	1	1	16
5	Natural Sciences	1	1	22

O. Vesterqvist

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Safety, Pharmacokinetics, and Pharmacodynamics of Single Doses of LXR‐623, a Novel Liver X‐Receptor Agonist, in Healthy Participants Arie Katz, Chandrasekhar Udata, Elyssa Ott, The Journal of Clinical Pharmacology	2009	201
Method Validation and Measurement of Biomarkers in Nonclinical and Clinical Samples in Drug Development: A Conference Report Jean W. Lee, Russ S. Weiner, Jeff M. Sailstad, Pharmaceutical Research Method ValidationBiomarker (Medicine)Prognostic BiomarkersPreclinical Drug EvaluationClinical Samples	2005	188
Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol) K. Grèen, Viktor Drvota, O. Vesterqvist Prostaglandins Medicinal ChemistryPharmaceutical ScienceVivo Prostacyclin SynthesisPharmacological StudyMedicine	1989	109
Determination of metformin in plasma by high-performance liquid chromatography after ultrafiltration O. Vesterqvist, Fizal Nabbie, Brian N. Swanson Journal of Chromatography B Biomedical Sciences and Applications BiochemistryGas ChromatographyMedicineAnalytical ChemistryLiquid Chromatography	1998	74
Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension Carlos M. Ferrario, Ronald D. Smith, Bridget Brosnihan, American Journal of Hypertension	2002	74
Urinary excretion of 2,3-dinor-thromboxane B2 in man under normal conditions, following drugs and during some pathological conditions O. Vesterqvist, Krister Gréen Prostaglandins Urological ResearchUrologyNormal ConditionsUrinary ExcretionMedicine	1984	71
Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1∝ and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs O. Vesterqvist, Krister Gréen Prostaglandins Urological ResearchUrologyNormal ConditionsMedicinePhysiology	1984	67
In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction. Peter Henriksson, Åke Wennmalm, O Edhag, Heart ThrombosisCardiovascular DiseaseAtherosclerosisPharmacologyVascular Biology	1986	62
Experimental atherosclerosis: effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation MONICA FOGELBERG, O. Vesterqvist, Ulf Diczfalusy, European Journal of Clinical Investigation	1990	59
Omapatrilat Versus Lisinopril Vito M. Campese, Kenneth C. Lasseter, Carlos M. Ferrario, Hypertension	2001	59

Page 1